Prostate Cancer - Treatment of Prostate Tumor in Israel

Prostate cancer can have devastating effects on men. Nevertheless, the most successfully treated if detected early. Almost 86 percent of all cases of prostate cancer are detected at a time when the tumor is located in the prostate gland. Early prostate cancer does not show any symptoms and can only be found with regular prostate examinations by a doctor. These tests can often detect, or help rule out prostate cancer. The doctor may prescribe additional studies or suggest repeating the PSA analysis.

The prostate gland that secretes the seminal fluid that carries the sperm out of the body through the urethra during ejaculation. The prostate gland is in front of the rectum under the bladder. Prostate cancer occurs when cells grow abnormally and form a tumor. Tumors of the prostate can develop under the influence of the male sex hormone, testosterone. More than 70% of all cases of prostate cancer are diagnosed in men over the age of 65 years.

Diagnosis of prostate cancer.

When diagnosing prostate cancer in Israel, 86% of all prostate cancer cases are detected while they are still localized. Thus, the treatment of prostate cancer in Israel provides a five-year survival rate of almost 100%. Several diagnostic tools: specific antigen (PSA) and digital rectal examination (DRE) are vital in early diagnosis, abnormally high levels of PSA and unusual growths, respectively, it is necessary to conduct several other tests to confirm the diagnosis of the prostate. The cancer center in Israel is likely to offer a biopsy and use other imaging technologies such as MRI, PET CT to help confirm the diagnosis and determine the most appropriate treatment for prostate cancer.

Treatment of malignant prostate cancer

The Department of Urologic Oncology offers the most advanced treatment for prostate cancer in Israel. Oncologists, urologists and radiologists work together to provide high-quality medical care. The clinic abroad offers a number of innovative therapies, often not available in other countries, such as stereotactic radiosurgery techniques, sparing neighboring healthy tissues, or prostatectomy with the robotic da-Vinci system

Laparoscopic prostatectomy robot provides more benefits than standard surgical treatment of prostate cancer: minimal blood loss, rapid recovery, and minimal catheter use. The new technology uses measuring instruments and two cameras for better visualization, which allows you to set up a three-dimensional image with a large magnification, which provides surgeons complete freedom of movement, and is associated with significantly less blood loss.

Operation is an ideal example of bloodless prostate surgery. In addition, the risk of sexual dysfunction and urinary incontinence decreases, because the surgeon has a clear understanding of anatomy and can more accurately navigate the nerves and structures responsible for these problems. Some surgeons believe that they should use their sense of touch and feeling in order to effectively remove cancer, but it is obvious that this is a myth. The laparoscopic approach provides additional benefits in the treatment of prostate cancer abroad.

Radiation therapy is a form of treatment for prostate cancer. It includes external radiation therapy (DLT) and brachytherapy. Remote radiation therapy is usually done after surgery, in cases with a high risk of relapse. It provides long-term disease control and high survival. Radiation therapy can cause many side effects. Some of them are insignificant and decrease after the termination of therapy. Side effects include fatigue, inflammation of the skin on the treated areas, frequent urination or rectal bleeding or irritation. Some side effects, however, are permanent. The functions of the intestine can not become normal even after cessation of treatment. Impotence can occur up to 2 years after treatment in some patients.

Cryosurgery, hormone therapy, chemotherapy and other methods of treating prostate cancer in Israel can be offered additionally. If necessary, the patient can enter into the program of clinical trials of experimental cancer treatments - a great way to fight prostate cancer.